Although many financial software developers have issued poor trading statements over the past month, Focus chairman Richard Jephcott claimed the group had 'bucked the trend' by delivering a set of interim results that 'demonstrated rapid progress'. Turnover during the period to September was £828,000, more than the group achieved in the previous 12 months. The pre-tax loss was also significantly higher, running up to £1.2m, against £1.0m in the previous year. The loss, however, was well within expectations. Highlights of the period included the expansion of the group's customer base. According to Jephcott, 66% of the UK's leading life and pension companies now employ the company's services in one capacity or another. Latest additions included the likes of Zurich IFA and Scottish Mutual. The group's 'Goal' product is also ready to be marketed to the mortgage sector and the first phase of Focus' advance point-of-sale system was delivered. The forecast for the full year to March 2001 is for Focus to lose around £2.0m on sales of £2.1m. Profitability is expected to come in 2002 when house brokers Beeson Gregory expect the group, which currently has a cash pile of £8.8m, to achieve profits of £1.0m on sales of almost £7.0m.
Market cap: £55.9m
PE Forecast: n/a
Share price: 223p
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.
Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.